| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/20/2005 | EP1554283A1 5-substituted 7,9-difluoro-5 i h /i -chromeno (3,4-f) quinoline compounds as selective progesterone receptor modulators |
| 07/20/2005 | EP1554277A1 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same |
| 07/20/2005 | EP1554272A1 Benzimidazoles and benzothiazoles as inhibitors of map kinase |
| 07/20/2005 | EP1554265A2 Compounds, compositions and methods |
| 07/20/2005 | EP1554256A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 07/20/2005 | EP1554254A1 Novel compounds |
| 07/20/2005 | EP1554253A1 Imidazolium cxcr3 inhibitors |
| 07/20/2005 | EP1554245A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 07/20/2005 | EP1553973A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 07/20/2005 | EP1553965A2 Method of treating tumors |
| 07/20/2005 | EP1553962A1 Combination chemotherapy with chlorotoxin |
| 07/20/2005 | EP1553948A1 Combination of a) n-(5(5-(4-methyl-piperazino-methyl)-benzoylamido)-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine and b) a histone deacetylase inhibitor for the treatment of leukemia |
| 07/20/2005 | EP1553940A1 Parenteral formulations containing a rapamycin hydroxyester |
| 07/20/2005 | EP1553939A1 Epothilone derivatives for the treatment of multiple myeloma |
| 07/20/2005 | EP1553938A1 Use of epothilone derivatives for the treatment of hyperparathyroidism |
| 07/20/2005 | EP1553935A2 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 07/20/2005 | EP1553933A1 Medicine comprising a thiourea for use as depigmenting agent or anti-mutagenic and anti-carcinogenic agent |
| 07/20/2005 | EP1553931A1 Compounds, compositions, and methods |
| 07/20/2005 | EP1553924A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/20/2005 | EP1553923A1 Camptothecin-carboxylate formulations |
| 07/20/2005 | EP1553912A1 Compositions and methods for the diagnosis and treatment of tumor |
| 07/20/2005 | EP1553911A2 2-heterosubstituted 3-aryl-4-h-1-benzopyran-4-ones as novel therapeutics in breast cancer |
| 07/20/2005 | EP1401467A4 Alpha-fetoprotein peptides and uses thereof |
| 07/20/2005 | EP1385852B1 Compounds and methods for inhibiting mrp1 |
| 07/20/2005 | EP1303512B1 Process for preparing arylacetylaminothiazoles |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1284959B1 Compounds for modulating the rage receptor |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1261328B1 Il-8 receptor antagonists |
| 07/20/2005 | EP1244672B1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 07/20/2005 | EP1189583B1 Indole derivatives |
| 07/20/2005 | EP1185493B1 Quinones for treatment of diseases |
| 07/20/2005 | EP1121137B1 Method for killing tumor and tumor associated endothelial cells using adenoviral mutants |
| 07/20/2005 | EP1011648B2 Combination of tyrosine kinase inhibitor and chemical castration to treat prostate cancer |
| 07/20/2005 | EP0910571B1 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 07/20/2005 | EP0814795B1 Topical use of betulinic acid for the treatment of malignant melanoma |
| 07/20/2005 | EP0759075B1 Apoptosis regulating gene |
| 07/20/2005 | EP0703785B1 Methods for treating muscle diseases and disorders |
| 07/20/2005 | CN1643382A A cytocapacity test |
| 07/20/2005 | CN1643380A Use of the MAL protein as a tumour marker |
| 07/20/2005 | CN1643377A Materials and methods for examining and treating nasopharyngeal carcinoma |
| 07/20/2005 | CN1643164A Recombinant bovine immunodeficiency virus based gene transfer system |
| 07/20/2005 | CN1643138A Novel cytokine ZCYTOR17 ligand |
| 07/20/2005 | CN1643135A Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 07/20/2005 | CN1643134A Method for producing pseudo islets |
| 07/20/2005 | CN1642984A Specific Ab1'-antibodies against tumour-associated antigen CA 125 |
| 07/20/2005 | CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 07/20/2005 | CN1642979A VEGF peptides and their use |
| 07/20/2005 | CN1642978A Peptides and peptidommetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 07/20/2005 | CN1642968A A human ribonucleotide reductase M2 subunit |
| 07/20/2005 | CN1642959A Novel dithiolopyrrolones with therapeutic activity |
| 07/20/2005 | CN1642958A Crystalline polymorphic form of irinotecan hydrochloride |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/20/2005 | CN1642931A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642922A Substituted indazoles with anti-cancer activity |
| 07/20/2005 | CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine |
| 07/20/2005 | CN1642917A Non-peptide GnRH antagonists |
| 07/20/2005 | CN1642915A Benzamide derivatives useful as histone deacetylase inhibitors |
| 07/20/2005 | CN1642913A Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially CCR5) |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642910A Synthesis of indole thiazole compounds as ligands for the AH receptor |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642573A Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 07/20/2005 | CN1642572A Remedy for glioblastoma |
| 07/20/2005 | CN1642571A Virus-like particles of human papillomavirus |
| 07/20/2005 | CN1642567A HIV inhibiting proteins |
| 07/20/2005 | CN1642560A Hyaluronic acid mediated adenoviral transduction |
| 07/20/2005 | CN1642557A Combination of an aldosterone receptor antagonist and nicotinic acid or a nicotinic acid derivative |
| 07/20/2005 | CN1642556A Combination of an aldosterone receptor antagonist and a bile acid sequestering agent |
| 07/20/2005 | CN1642552A 4-(N-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 07/20/2005 | CN1642551A Inhibitors of histone deacetylase |
| 07/20/2005 | CN1642542A Angiogenesis inhibitors |
| 07/20/2005 | CN1642528A Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 07/20/2005 | CN1641035A Plasmid of recombinant immunotoxin IP 10-DT 390 aimed at activating Th1 cell, and its preparing method and use |
| 07/20/2005 | CN1641024A Anti EB virus resulted tumour polypeptide, and its use and preparing method |
| 07/20/2005 | CN1641021A NDRG2 and NDRG4 protein and their use for diagnosing and suppressing tumour |
| 07/20/2005 | CN1640890A Cell withering factor derivated from placents |
| 07/20/2005 | CN1640887A 'Heat shock protein special extraction kit' for biological therapy |
| 07/20/2005 | CN1640873A Separation and extraction of flavone natural product active component for treating prostating disorders and medicinal preparation preparing and use thereof |
| 07/20/2005 | CN1640498A Magnetic nano radioactive medicine and its preparing method |
| 07/20/2005 | CN1640490A Urine polyacid peptide composition and its use |
| 07/20/2005 | CN1640489A Method for preparing urine polyacid peptide composition |
| 07/20/2005 | CN1640488A Method for preparing supermicro powder preparation of cordyceps sinensis mycelium |
| 07/20/2005 | CN1640446A Medicine for treating cancer |
| 07/20/2005 | CN1640444A Fresh tea juice preparation and its preparing method |
| 07/20/2005 | CN1640432A Anti-tumour medicine, its preparing method and novel use |
| 07/20/2005 | CN1640414A Chinese medicine for treating cancer |
| 07/20/2005 | CN1640403A Use of cis-butenedionic acylhydrazine for preparing medicine for treating cancers |
| 07/20/2005 | CN1211386C Antitumoral analogue of Et-743 |
| 07/20/2005 | CN1211383C Process for making substituted 8-arylquinolinium benzenesulfonate |
| 07/20/2005 | CN1211382C Quinazoline ditosylate salt compounds |
| 07/20/2005 | CN1211375C Thiazole-derivatives |
| 07/20/2005 | CN1211374C Heterocyclic derivative, its preparation method and medicine compositioncontaining them |
| 07/20/2005 | CN1211373C 2,d-di (hetero-) arylamino (-oxy)-5-substituted pyrimidines as antineoplastic agents |
| 07/20/2005 | CN1211368C Amorphous torasemide modification |
| 07/20/2005 | CN1211127C Nanoscale particles having iron oxide-containing core enveloped by at least two shells |
| 07/20/2005 | CN1211126C Vascular endothelial growth factor 2 |
| 07/20/2005 | CN1211110C Chinese medicine composition for treating tumour and preparation method |
| 07/20/2005 | CN1211105C Syrup for treating gastric cancer and its preparing process |